Blueprint Medicines to buy cancer drug startup with potential edge over Takeda, J&J ...

The startup's lead drug candidate is on track to begin human testing in ... last year and backed it with a $15 million Series A round of funding.

https://ift.tt/319O3RS

Post a Comment

0 Comments